Symbol="FOLD"
AssetType="Common Stock"
Name="Amicus Therapeutics Inc"
Description="Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing and delivering drugs for people living with rare metabolic diseases. The company is headquartered in Philadelphia, Pennsylvania."
CIK="1178879"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1 CEDAR BROOK DRIVE, CRANBURY, NJ, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="3692376000"
EBITDA="-122731000"
PERatio="None"
PEGRatio="-0.18"
BookValue="0.389"
DividendPerShare="0"
DividendYield="0"
EPS="-0.65"
RevenuePerShareTTM="1.206"
ProfitMargin="-0.529"
OperatingMarginTTM="-0.367"
ReturnOnAssetsTTM="-0.105"
ReturnOnEquityTTM="-1.3"
RevenueTTM="350560000"
GrossProfitTTM="290634000"
DilutedEPSTTM="-0.65"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.171"
AnalystTargetPrice="16.4"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="10.51"
PriceToBookRatio="24.77"
EVToRevenue="10.46"
EVToEBITDA="-15.91"
Beta="0.839"
num_52WeekHigh="14.1"
num_52WeekLow="9.1"
num_50DayMovingAverage="12.94"
num_200DayMovingAverage="12.21"
SharesOutstanding="287121000"
DividendDate="None"
ExDividendDate="None"
symbol="FOLD"
open="12.74"
high="12.87"
low="12.40"
price="12.86"
volume="1687120.00"
latest_trading_day="2023-08-25"
previous_close="12.68"
change="0.18"
change_percent="1.4196%"
aroon_positive_momentum_days="57"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="57"
Volume_recent_avg="2483649"
Change_recent_avg="0.02"
Delta_recent_avg="0.41"
Variance_recent_avg="0.2"
Change_ratio_recent_avg="0.15"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="57"
Aroon_momentum_negative="43"
image_negative_thumbnail_id_1="92"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0084.jpeg"
image_negative_thumbnail_id_2="105"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0071.jpeg"
image_neutral_thumbnail_id_1="542"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0057.jpeg"
image_neutral_thumbnail_id_2="565"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0034.jpeg"
image_positive_thumbnail_id_1="960"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0122.jpeg"
image_positive_thumbnail_id_2="687"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0021.jpeg"
image_professor_thumbnail_id_1="1198"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0032.jpeg"
image_professor_thumbnail_id_2="1195"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
